Discovering Biomarkers of Human Disease and Development Using Stem Cells and Metabolomics [ASMS 2010]
Stemina presented at the Agilent Users Meeting in Salt Lake City on May 22, 2010 at the American Society of Mass Spectrometry annual meeting.
Stemina’s neurological disorders business unit has developed a test to aid in the earlier diagnosis of autism spectrum disorder.
